Frequently Asked Questions
What is Brainomix 360?
Brainomix 360 is a suite of FDA-cleared, CE-marked AI imaging tools that help clinicians make faster, more confident decisions — across stroke and lung disease. The platform is used in 400+ hospitals worldwide.
What products does Brainomix offer?
The platform covers two clinical areas and an analytics dashboard:
• Brainomix 360 Stroke — AI decision support for NCCT, CTA, CTP, and MRI across the acute stroke pathway
• Brainomix 360 e-Lung — AI-powered workflow enhancement, visualization, and quantification for CT thoracic datasets
• Brainomix 360 Vantage — enterprise analytics dashboard for network-wide clinical and operational insights
• Brainomix 360 Stroke — AI decision support for NCCT, CTA, CTP, and MRI across the acute stroke pathway
• Brainomix 360 e-Lung — AI-powered workflow enhancement, visualization, and quantification for CT thoracic datasets
• Brainomix 360 Vantage — enterprise analytics dashboard for network-wide clinical and operational insights
Is Brainomix 360 a replacement for clinical judgement?
No. Every Brainomix module is a decision support tool — designed to enhance clinical decision-making by providing objective, reproducible, and quantitative results. All final decisions remain with the treating clinician.
What regulatory clearances does Brainomix 360 hold?
Brainomix 360 holds regulatory clearances and certifications in multiple markets worldwide, including:
FDA-cleared medical devices in the United States.
CE-marked Class IIb medical devices certified under the EU Medical Device Regulation (EU MDR), supporting commercialization across Europe, the United Kingdom, and other markets that recognize or leverage CE marking
Regulatory approvals, registrations, or market authorizations in additional countries and regions where applicable, in accordance with local regulatory requirements.
FDA-cleared medical devices in the United States.
CE-marked Class IIb medical devices certified under the EU Medical Device Regulation (EU MDR), supporting commercialization across Europe, the United Kingdom, and other markets that recognize or leverage CE marking
Regulatory approvals, registrations, or market authorizations in additional countries and regions where applicable, in accordance with local regulatory requirements.
What modules are available for stroke?
Brainomix 360 Stroke includes the following modules, each independently licensed or available as a package:
• NCCT — automated ASPECTS scoring, LVO detection, ischemic core volume, Net Water Uptake, and intracranial hemorrhage (ICH) detection
• CTA — LVO detection, automated collateral score (CTA-CS) (*CE-mark only), multi-phase CTA support
• CTP — perfusion summary maps, mismatch estimation
• MRI — DWI, DWI-FLAIR mismatch (*CE-mark only), and DSC perfusion analysis for late-window patients
• NCCT — automated ASPECTS scoring, LVO detection, ischemic core volume, Net Water Uptake, and intracranial hemorrhage (ICH) detection
• CTA — LVO detection, automated collateral score (CTA-CS) (*CE-mark only), multi-phase CTA support
• CTP — perfusion summary maps, mismatch estimation
• MRI — DWI, DWI-FLAIR mismatch (*CE-mark only), and DSC perfusion analysis for late-window patients
How quickly are results generated?
Results are typically available within 1–2 minutes of a scan being sent to the platform, delivered automatically via PACS, email notification, the Brainomix 360 mobile app, or web browser.
Which scanners and PACS systems are compatible?
Brainomix 360 Stroke supports all major scanner and PACS manufacturers using the standard DICOM protocol. Brainomix engineers test all connections before go-live.
What is ASPECTS and why does it matter?
ASPECTS (Alberta Stroke Programme Early CT Score) is a 10-point scale used to quantify early ischemic changes on non-contrast CT. A lower ASPECTS score indicates more brain damage. Brainomix's NCCT module automates this score with a patented voxel-wise heatmap, delivering expert-level results in under 2 minutes — validated as non-inferior to expert scorers in a multicenter study.
What is Net Water Uptake (NWU)?
Net Water Uptake (NWU) is a standardized, percentage-based quantitative measure derived from non-contrast CT (NCCT) images that reflects changes in tissue water content associated with ischemic brain tissue. In the published literature, NWU has been associated with the severity of tissue injury and clinical outcomes in acute ischemic stroke.
Can results be manually adjusted?
Yes. Clinicians can review and edit automated ASPECTS results. Manually adjusted results are clearly labelled and published to all result formats.
Can I access results from outside the hospital?
Yes. Pseudonymized email notifications are accessible from any device with hospital email access. Full results are available remotely via any existing VPN or Citrix solution, and through the Brainomix 360 mobile app (iOS and Android).
What does the Lancet Digital Health study show?
The largest ever real-world evaluation of stroke AI — 452,000 patients, 107 hospitals, 5 years — published in The Lancet Digital Health (2025) showed that Brainomix 360 Stroke was associated with a 100% relative increase in mechanical thrombectomy rates.
What is Core Volume?
Core Volume is the estimated volume of irreversibly damaged (infarcted) brain tissue, measured in ml. Brainomix 360 can assess Core Volume directly from routine NCCT scans — without needing CTP or MRI — with results shown to be equivalent to CTP-derived assessments in a study of 111 patients (20.4ml vs 19.9ml, P=0.82).¹
1. Shahrouki P, Kihira S, Tavakkol E, et al. Automated assessment of ischemic core on non-contrast computed tomography: a multicenter comparative analysis with CT perfusion. J Neurointerv Surg. 2024;16(12):1288-1293. doi:10.1136/jnis-2023-020954
1. Shahrouki P, Kihira S, Tavakkol E, et al. Automated assessment of ischemic core on non-contrast computed tomography: a multicenter comparative analysis with CT perfusion. J Neurointerv Surg. 2024;16(12):1288-1293. doi:10.1136/jnis-2023-020954
What is e-Lung?
Brainomix e-Lung is an FDA-cleared, AI-powered imaging software platform that automatically identifies and quantifies features on CT lung scans enabling clinicians to more easily identify changes including subtle deteriorations over multiple scan timepoints.
What CT scans does e-Lung accept?
e-Lung is designed to work with chest CT scans sent via the DICOM protocol. Information on CT image acquisition and compatibility characteristics are available from Brainomix on request.
Is e-Lung FDA-cleared?
Yes, e-Lung is FDA cleared for clinical use in the United States.
What is Brainomix 360 Vantage?
Vantage is the enterprise analytics dashboard that turns your AI imaging results into real-time, actionable insights across your entire stroke network. It provides a 360° view of clinical outcomes, clinician engagement, imaging throughput, and operational efficiency — across all sites, in one intuitive interface.
What can I measure with Vantage?
• Clinical outcomes — LVO detections, ASPECTS distribution, pathway tracking from triage to intervention
• Adoption & engagement — clinician app usage, time to first view, interventions over time
• Operational efficiency — processing speeds, CTA quality assurance, clinical workflow timings (door-to-door, groin puncture)
• Site benchmarking — compare performance across your network
• Adoption & engagement — clinician app usage, time to first view, interventions over time
• Operational efficiency — processing speeds, CTA quality assurance, clinical workflow timings (door-to-door, groin puncture)
• Site benchmarking — compare performance across your network
Who is Vantage for?
Stroke network leads, clinical directors, and quality improvement teams who need visibility across multiple sites. It is particularly valuable for comprehensive stroke centres managing spoke-and-hub networks.
How is Brainomix 360 installed?
Brainomix 360 is provided as a managed appliance on virtualized (cloud) or physical hardware. Brainomix engineers handle installation, scanner/PACS connections, protocol setup, and go-live testing in partnership with your hospital IT team.
What training is provided?
All clinical users receive a group training presentation covering how to interpret results for each licensed module. User manuals are available in multiple languages at www.brainomix.com/docs. Please see URL to request access (only available for current customers).
How do I get technical support?
Contact the Brainomix support team:
• Email: support@brainomix.com
• Support portal: www.brainomix.com/support/contact-us
• UK office: +44 (0) 1865 582 730
• EU office: +353 1 636 3150
• Email: support@brainomix.com
• Support portal: www.brainomix.com/support/contact-us
• UK office: +44 (0) 1865 582 730
• EU office: +353 1 636 3150
How is patient data kept secure?
Patient data is stored on the Brainomix server inside the hospital and is not transmitted externally. Email notifications contain pseudonymized results only. Brainomix is ISO 27001 certified and GDPR compliant. A Data Processing Agreement (DPA) is available on request.
How do I request a demo?
Visit www.brainomix.com/request-a-demo to schedule a personalized demo with a Brainomix clinical specialist.
Brainomix Limited is a company registered in England and Wales at OX2 0JJ. Company Registration No. 07426406
International
Brainomix © 2026. All rights reserved